Topical sirolimus for oral pemphigus vulgaris: 3 unresponsive cases.
Angelique M
AM
Poot
Marcel F
MF
Jonkman
D000287:Administration, Topical; D000328:Adult; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy* / Q000473:pathology; D009061:Mouth Mucosa / Q000187:drug effects / Q000473:pathology; D009067:Mouthwashes; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D017211:Treatment Failure
D007166:Immunosuppressive Agents; D009067:Mouthwashes; D020123:Sirolimus